Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.
Repare Therapeutics(US:RPTX) Businesswire·2026-01-17 05:58公司交易 - 临床阶段精准肿瘤学公司Repare Therapeutics Inc宣布其股东已批准由非营利生物技术公司XenoTherapeutics, Inc.和Xeno Acquisition Corp联合收购公司所有已发行和流通的普通股 [1]